S 4302 · 117th Congress
Biologics Market Transparency Act of 2022
This bill requires drug manufacturers to be more open about the prices they charge for biologic medications—drugs made from living cells that treat serious conditions like cancer, rheumatoid arthritis, and certain infections. Right now, these companies can keep their pricing strategies largely secret, which makes it…
- Sponsor
- Kaine, Tim (D-VA)
- Introduced
- 2022-05-25
- Policy area
- Health
- Latest action
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709)
Digging through Congress... 🔍